| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |